Nociceptive Monitoring Technology Reduces Postoperative Pain
By HospiMedica International staff writers Posted on 31 May 2021 |
Image: An intraoperative monitor can help reduce subsequent pain (Photo courtesy of Medasense)
A unique device that can monitor a patient’s sympathetic system response levels during surgery can help reduce postoperative pain.
The Medasense (Ramat Gan, Israel) PMD-200 is designed to objectively monitor and quantify a patient's pain response during a surgical procedure by means of artificial intelligence (AI) and a proprietary non-invasive probe that fits over the patient's finger and incorporates four different multi-sensors. A nociception level (NOL) index score is derived from dozens of physiological parameters extracted from the data and displayed either on the stand-alone monitor or on a connected Philips IntelliVue patient monitor.
A recent study from Leiden University Medical Center (LUMC, The Netherlands) that explored the potential use of NOL monitoring to help enhance recovery after surgery found that pain scores were 33% lower when administration of pain medication during surgery was guided with NOL monitoring. Also, an economic analysis by Coreva Scientific (Königswinter, Germany) found that these outcomes could enable a 22% reduction in healthcare costs associated with acute postoperative pain treatments, pain-related readmissions, and emergency room visits.
“Medical technology should always aim to achieve the two core goals that justify adoption in the market: improved patient care and cost savings,” said Mira Sofer, VP of business development and marketing at Medasense. “Recent NOL studies and the economic analysis conducted by Coreva Scientific emphasize the benefit of preferring NOL monitoring over current standard of care, for better patient outcomes and lowering healthcare expenditures.”
Activation of the sympathetic nervous system, as a result of multiple stimuli and inputs, leads to a constellation of nociception-related physiological responses, with complex inter-associations and different response profiles. Recognizing the complex nature of this process, the NOL index serves as a composite quantifier of autonomic signals.
Related Links:
Medasense
Leiden University Medical Center
Coreva Scientific
The Medasense (Ramat Gan, Israel) PMD-200 is designed to objectively monitor and quantify a patient's pain response during a surgical procedure by means of artificial intelligence (AI) and a proprietary non-invasive probe that fits over the patient's finger and incorporates four different multi-sensors. A nociception level (NOL) index score is derived from dozens of physiological parameters extracted from the data and displayed either on the stand-alone monitor or on a connected Philips IntelliVue patient monitor.
A recent study from Leiden University Medical Center (LUMC, The Netherlands) that explored the potential use of NOL monitoring to help enhance recovery after surgery found that pain scores were 33% lower when administration of pain medication during surgery was guided with NOL monitoring. Also, an economic analysis by Coreva Scientific (Königswinter, Germany) found that these outcomes could enable a 22% reduction in healthcare costs associated with acute postoperative pain treatments, pain-related readmissions, and emergency room visits.
“Medical technology should always aim to achieve the two core goals that justify adoption in the market: improved patient care and cost savings,” said Mira Sofer, VP of business development and marketing at Medasense. “Recent NOL studies and the economic analysis conducted by Coreva Scientific emphasize the benefit of preferring NOL monitoring over current standard of care, for better patient outcomes and lowering healthcare expenditures.”
Activation of the sympathetic nervous system, as a result of multiple stimuli and inputs, leads to a constellation of nociception-related physiological responses, with complex inter-associations and different response profiles. Recognizing the complex nature of this process, the NOL index serves as a composite quantifier of autonomic signals.
Related Links:
Medasense
Leiden University Medical Center
Coreva Scientific
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure